Fig. 2From: The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic targetSchematic representation of hepatocellular carcinoma indicates that FOXO3a, an inhibitor of β-catenin/TCF pathway, is suppressed by miR-182, leading to cell proliferation. On the other hand, miR-182 targets FOXO1, an apoptosis inducer, and suppresses cell apoptosis, which can be reversed by LINC0108 expressionBack to article page